「and」の検索結果
113件：46～50件目を表示
-
お知らせ | 千寿製薬株式会社
2026年06月01日 Launch of Distribution of 3in1Smart and SPM-700（PDF） 2026年04月06日 Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition（PDF...
https://www.senju.co.jp/chinese/news/ -
General Announcement: February 20, 2025 Senju Pharmaceutical Co., Ltd. Launch and Distribution of “MIEr for BeelineMED” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distr...
https://www.senju.co.jp/system/files/content_news/2025-02/ENG_20250220_0.pdf -
製品開発方針 | 研究開発活動 | 千寿製薬株式会社
X, Li X, Cheung CM, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob ...
https://www.senju.co.jp/rd/policy/ -
General Announcement: February 20, 2025 Senju Pharmaceutical Co., Ltd. Launch and Distribution of “MIEr for BeelineMED” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distr...
https://www.senju.co.jp/system/files/content_news/2025-02/ENG_20250220.pdf -
f Phase III clinical trials in Japan, which consisted of the comparative (placebo-controlled) trial and the long-term administration trial. During the comparative trial, the primary efficacy endpoints...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716.pdf